Prostate Cancer Gene Expression Marker 1 (PCGEM1): A Patented Prostate- Specific Non-Coding Gene and Regulator of Prostate Cancer Progression

Publisher： Bentham Science Publishers

E-ISSN： 2212-3431|3|3|151-163

ISSN： 1872-2156

Source： Recent Patents on DNA & Gene Sequences, Vol.3, Iss.3, 2009-11, pp. : 151-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Patents on Interventional Robot for Prostate Cancer

By  

Recent Patents on Mechanical Engineering, Vol. 9, Iss. 4, 2017-01 ,pp. : 281-288

Bentham Science Publishers

Access to resources Recommend Favorite

Aberrant Activation of Arachidonic Acid and Eicosanoid Pathways-Targets for Treating Prostate Cancer

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 2, Iss. 1, 2008-01 ,pp. : 9-15

Bentham Science Publishers

Access to resources Recommend Favorite

Prospective Trial of an Herbal Formula BYSH and Saw Palmetto in Patients with Hormonal Refractory Prostate Cancer: A Pilot Study

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 8, Iss. 3, 2014-09 ,pp. : 196-202

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of ColE1-Like Plasmid Replication for Recombinant Gene Expression

By  

Recent Patents on DNA & Gene Sequences, Vol. 4, Iss. 1, 2010-01 ,pp. : 58-73

Bentham Science Publishers

Access to resources Recommend Favorite

Patented Applications of Gene Silencing in Plants: Manipulation of Traits and Phytopathogen Resistance

By  

Recent Patents on DNA & Gene Sequences, Vol. 4, Iss. 3, 2010-11 ,pp. : 167-180

Bentham Science Publishers

Access to resources Recommend Favorite